Patent · US Active

Compounds and compositions for the treatment of parasitic diseases

US9303034B2 · kind B2 · utility

2Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2014
Grant dateApr 5, 2016
Priority date
Expiry dateDec 18, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula A:or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as leishmaniasis, human African trypanosomiasis and Chagas disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.